About Dr. Daniel Cameron

Dr. Daniel Cameron, MD, MPH, is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick-borne illnesses. For more than 32 years, he has been treating adolescents and adults suffering from Lyme disease.

Dr. Daniel Cameron and Associates

Dr. Daniel Cameron & Associates, located in Mount Kisco, NY, has been serving patients since 1987. He also is affiliated with Northern Westchester Hospital in Mount Kisco. Within a year of opening his practice, Dr. Cameron, a board-certified internist and epidemiologist, began treating a growing number of patients exhibiting persistent, recurrent symptoms, including neurological manifestations, caused by chronic Lyme disease. He has since treated thousands of Lyme disease patients and become a pioneer in the field.

After receiving his medical degree from the University of Minnesota Medical School in 1981, he earned a master’s degree in public health from the University of Minnesota, which focused on chronic illness. After completing residencies at Beth Israel Medical Center and Mt. Sinai School of Medicine in New York City, Dr. Cameron served as Assistant Professor of Medicine in Geriatrics at the New York College of Medicine. He has also been heavily involved in clinical research.

Research and Teaching

His interest in research and teaching continues at his private practice where he manages the Lyme Disease Practice and Research (LDPR) project and mentors health care practitioners interested in learning more about Lyme and tick-borne diseases. Physicians and practitioners, from across the country, visit his office to receive on-site training and education in diagnosing and treating all stages of Lyme disease. Meanwhile, ongoing clinical trials are performed through the LDPR in an effort to improve the level of care for Lyme disease patients.

Dr. Cameron’s patient, educated and consistent care has brought me back to health.

Laurie M.

Leadership

Dr. Cameron is the past president of the International Lyme and Associated Diseases Society (ILADS), a nonprofit medical society dedicated to improving the diagnostic and treatment standards of tick-borne diseases. He is the lead author of ILADS’ evidence-based treatment guidelines, and is actively involved in raising awareness and in educating the medical community about the complexity of the disease.

Publications and Media

He has published more than 30 scientific papers, analytic reviews and clinical trials and presented at numerous international medical conferences. As an expert on Lyme disease, Dr. Cameron has testified for multiple legislative hearings across the country and is frequently interviewed by the media. He has appeared on CNN, Good Morning America, the Today Show, Fox News and National Public Radio and has been interviewed by The New York Times, Wall Street Journal, Discover Magazine, National Geographic magazine, and the Huffington Post, among others.

Dr. Daniel Cameron Education & Experience

Education & Experience

Daniel Cameron, MD, MPH, is a board-certified internist and epidemiologist and a nationally recognized expert in the treatment of tick-borne diseases.

Dr. Daniel Cameron speaking at St. Joseph’s Hospital Grand Rounds, Syracuse, NY

He has lectured at numerous medical and scientific conferences in the United States, Europe and Canada and is often interviewed by the news media, including nationally syndicated radio and television programs. In addition to his clinical background, Dr. Cameron has been actively involved in research and is the lead author of the International Lyme and Associated Diseases Society’s (ILADS) treatment guidelines for tick-borne diseases.

Dr. Cameron received his M.D. degree from the University of Minnesota Medical School and a Master’s in Public Health from the University of Minnesota and completed residencies at Beth Israel Medical Center and Mt. Sinai Medical Center. For more than 25 years, he has been treating patients with Lyme and other tick-borne diseases through his private practice in Westchester County, New York.

Download Resume

Resume

License

M.D. - New York State

Education

University of Minnesota, M.P.H. 1983

Epidemiology

University of Minnesota, M.D. 1981

Medicine

University of Minnesota, B.A. 1976

Chemistry

Certification

Geriatric Medicine 1987

Board Eligible

Internal Medicine 1985

Board Certified

Preventive Medicine 1985

Board Eligible

Internship

Beth Israel Medical Center 1982 – 1983

Residencies

Mt. Sinai Medical Center 1984 – 1985

Beth Israel Medical Center 1983 – 1985

Employment

Medical Director 1987 – Present

Dr. Daniel Cameron & Associates
Mount Kisco, NY

Attending Physician 1987 – Present

Northern Westchester Hospital
Mount Kisco, NY

Geriatrician 1987 – 1988

Veterans Administration Hospital
Montrose, NY

Faculty 1986 – 1987

Mid-Hudson Geriatric Education Center
Mount Sinai School of Medicine
New York, NY

Assistant Professor of Medicine 1985 – 1987

Division of Geriatrics and Gerontology
Department of Medicine
New York Medical College
Valhalla, NY

Director 1985 – 1987

Dementia Unit
Ruth Taylor Geriatric and Rehabilitation Institute
Hawthorne, NY

Consulting Geriatrician 1985 – 1987

Bird S. Coller Memorial Hospital
Roosevelt Island, New York, NY

Physician 1981 – 1982

Cancer Detection Center
University of Minnesota
Minneapolis, MN

Teaching Assistant 1973 – 1975

Physics Department
University of Minnesota-Morris
Morris, MN

Investigational Studies

Investigational
Studies

Genzyme

REACH Program
An International Prospective Observational Registry in Subjects at Risk of Atherothrombotic Events

Watson

MATRIX Trial
Multi-center Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin TDS

Merck

Migraine Therapy Evaluation Protocol
Multi-center, Open-label, Crossover Study Comparing Maxalt with Usual Care Oral Migraine Medication

Daniel Cameron, M.D., M.P.H.

Investigator - Pfizer Gemini Study
Combination Norvasc and Lipitor
Phase IIIb Open-label, multi-center trial

Daniel Cameron, M.D., M.P.H.

Principal investigator - Lyme Disease Retreatment Study
Double-Blind Randomized Placebo-controlled

Daniel Cameron, M.D., M.P.H.

Sub-investigator - Lyme Disease Retreatment Study
Mt. Sinai School of Medicine

Upjohn

Wound and soft tissue infection

Eli Lilly

Streptococcal pharyngitis
Uncomplicated urinary tract infection
Wound and soft tissue infection

G.D. Searle

Analgesic (phase I, II)

Squibb

Generalized anxiety

Eli Lilly

Acute bronchitis

Glaxo

Lyme Disease

Ciba-Geigy

Hypertension

Professional Societies

Professional
Societies

American Medical Association 1987 – Present

Member

International Lyme and Associated
Diseases Society (ILADS) 2001 – Present

Board Member

International Lyme and Associated
Diseases Society (ILADS) 2013 – Present

President

International Lyme and Associated
Diseases Society (ILADS) 2007 – 2009

President

Infectious Diseases Society of America (IDSA) 2006 – Present

Member

Medical Society of the State of New York (MSSNY) 2005 – Present

Member

Association of America Physicians and Surgeons 2012 – Present

Member

Conference Abstracts

Conference Abstracts and Presentations

1. Cameron DJ. Paradigm Shift from Acute to Chronic Lyme Disease. Tick-borne Disease Symposium, London, June, 2014.
2. Cameron DJ. Evidence-based Lyme disease Treatment. St. Joseph’s Hospital Grand Rounds, Syracuse, NY, May, 2014.
3. Cameron DJ. Evidence-based Practice. The Annual Conference of the Deutsche-Borreliose-Gesellschaft (German Borreliosis Society), Hamburg, Germany, April, 2013.
4. Cameron DJ. ILADS Treatment Guidelines Update. Lyme and Tick-borne Diseases Conference, International Lyme and Associated Diseases Society (ILADS), Hershey, PA, April, 2013.
5. Cameron DJ. Goal Directed Therapy of Lyme and Tick-Borne Diseases. International Lyme and Associated Diseases Society (ILADS) Professional Conference, Boston, 2012.
6. Cameron DJ. Building an Evidence-based Lyme Practice. International Lyme and Associated Diseases Society Professional Conference, Boston, 2012.
7. Cameron DJ. Interpreting and Using Laboratory Tests in Practice. International Lyme and Associated Diseases Society Professional Conference, Boston, 2012.
8. Cameron DJ. Retreatment of Chronic Lyme disease. International Lyme and Associated Diseases Society Professional Conference, Boston, 2012.
9. Cameron DJ. ILADS Treatment Guidelines Update. International Lyme and Associated Diseases Society Professional Conference, Toronto, Canada, 2011.
10. Cameron DJ. Research Workshop. International Lyme and Associated Diseases Society Annual Scientific Meeting, Jersey City, NJ, 2010.
11. Cameron DJ. 21st Century ILADS Keynote address. ILADS Innovations. International Lyme and Associated Diseases Society Annual Scientific Meeting, Washington DC, 2009.
12. Cameron DJ. Lyme Disease Prevention. International Lyme and Associated Diseases Society Annual Scientific Meeting, San Francisco, 2008.
13. Cameron DJ. Lyme disease Integration of the Best Evidence with Clinical Expertise and Patient Values into Clinical Practice Guidelines. International Lyme and Associated Diseases Society Annual Scientific Meeting, Boston, 2007.
14. Cameron DJ. Designing Research in the Clinical Setting. John Drulle Memorial Lecture, Lyme Disease Association’s 7th Annual Lyme Disease Conference, Philadelphia, 2006.
15. Cameron DJ. Consequences of Delayed Treatment. Lyme Disease Association’s 7th Annual Lyme Disease Conference, Philadelphia, 2006.
16. Cameron DJ. Update ILADS Evidence-based Guidelines. International Lyme and Associated Diseases Society Annual Scientific Meeting. Philadelphia, 2006.
17. Cameron DJ. Generalizability in Two Clinical Trials of Chronic Lyme disease. International Lyme and Associated Diseases Society Annual Scientific Meeting, Philadelphia, 2006.
18. Cameron DJ. Lyme disease Clinical Trial – Validation of ILADS Treatment Guidelines. International Lyme and Associated Diseases Society Annual Scientific Meeting, Philadelphia, 2005.
19. Cameron DJ. Lyme disease Clinical Trial – Quality of Life. Lyme Disease Association’s 6th Annual Lyme Disease Conference, Philadelphia, 2005.
20. Cameron DJ. Lyme disease POEM - Timely treatment – Patient-oriented Evidence That Matters. International Lyme and Associated Diseases Society, October, 2004.
21. Cameron DJ. VOLT – Validation of Lyme treatment. International Lyme and Associated Diseases Society Scientific Meeting. Philadelphia, 2003.
22. Cameron DJ, Gaito A, Harris N, et al. Lyme disease Practice Treatment Guidelines. International Lyme and Associated Diseases Society, August, 2002.
23. Cameron DJ. Integrating Intramuscular Benzathine Penicillin into the Treatment of Chronic Lyme Disease. Submitted, International Conference on Lyme Borreliosis, New York, NY, 2002.
24. Cameron DJ. Feasibility of Randomized Double-Blind Placebo-Controlled Clinical Trials in Lyme Disease: Lyme Disease Retreatment Study. Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis, New York, NY, 2002.
25. Cameron DJ. The Consequence of Underdiagnosing and Undertreating Lyme Disease: The Lyme Disease Surveillance Database Study Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis, New York, NY, 2002.
26. Cameron DJ. Selection Bias in Clinical Trials of Lyme Disease Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis, New York, NY, 2002.
27. Cameron DJ. Validation of Lyme Disease Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis. New York, NY, 2002.
28. Cameron DJ, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey CE, Horowitz R, Phillips S, Merr-Sherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R. Primary Changes in ILADS Evidence-Based Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis, New York, NY, 2002.
29. Cameron DJ. Practice Treatment Guidelines. International Lyme and Associated Diseases Society, Princeton, NJ, 2001.
30. Cameron DJ. Lyme Disease Retreatment Study. Launched Double-Blind, Randomized Placebo-controlled Study of the Efficacy and Safety of Retreating Seropositive and Seronegative Lyme Disease. Presented at the 14th Annual International Scientific Conference on Lyme Disease and Other Spirochetal & Tick-Borne Disorders. Farmington, CT, 2001.
31. Cameron DJ. 21st Century Lyme Disease. Presented at the 14th Annual International Scientific Conference on Lyme Disease and Other Spirochetal & Tick-Borne Disorders, Farmington, CT, 2001.
32. Cameron DJ. Off-Season Lyme Disease. In Abstracts of the 14th Annual International Scientific Conference on Lyme Disease and Other Spirochetal & Tick-Borne Disorders, Farmington, CT, 2001.
33. Cameron DJ. Insensitivity of the IgG Western Blot and CDC surveillance case definition - Impact on clinical trials. In Abstracts of the 13th Annual International Scientific Conference on Lyme Disease and Other Spirochetal & Tick-Borne Disorders, Farmington, CT, 2000.
34. Cameron DJ. Failure of the Western Blot as a Confirmatory Test for Lyme Disease. Proceedings of the 8th International Conference on Lyme Borreliosis. Germany, 1999.
35. Cameron DJ. Successful treatment of Lyme diseases relapses. Proceedings of the 8th International Conference on Lyme Borreliosis, Germany, 1999.
36. Cameron DJ. First Sentinel Health Site for Lyme disease - a prospective cohort study. Proceedings of the 8th International Conference of Lyme Borreliosis, Germany, 1999.
37. Cameron DJ. Monitoring Lyme Disease in the Community - First Sentinel Health Site. In Abstracts of the 12 Annual International Scientific Conference on Lyme Disease and Other Spirochetal and Tick-Borne Disorders, New York, NY, 1998.
38. Cameron DJ. First Sentinel Health Site for Monitoring Lyme Disease - Monitoring Lyme Disease in the Community. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, April 19-April 21, 1998, New York, NY.
39. Cameron DJ. Guidelines for the Diagnosis and Management of Chronic Lyme Disease. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, April 21-April 23, 1998, New York, NY.
40. Cameron DJ., Malara VP., Treatment Denials for Lyme Disease by Managed Care. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996. San Francisco.
41. Malara VP, Cameron DJ. Non-confirmed ELISA Testing for Lyme Disease: Bayes' Theorum Consideration. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996 San Francisco.
42. Cameron DJ., Malara VP. Clinical Features of IgM Western Blot Lyme Borreliosis. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996. San Francisco.
43. Cameron DJ., Malara VP., Geriatric Lyme Disease. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, May 19-May 23, 1994, Stamford, CT.
44. Malara VP, Cameron DJ. Depressive Symptomalogy in Lyme Disease. Presented at the Sixth International Conference on Lyme Borreliosis, June 19-June 24, 1994, Bologna, Italy.
45. Cameron DJ., Malara VP. O'Dell C, Schreck C. Age Factor in Lyme Disease. Presented at the Sixth International Conference on Lyme Borreliosis, June 19-June 24, 1994, Bologna, Italy.
46. Malara VP, Cameron DJ. Outcome of Oral Antibiotic Treatment of Lyme Disease in a Community Setting. Presented at the Fifth International Conference on Lyme Borreliosis, May 30,-June 2, 1992, Arlington, VA.
47. Cameron DJ, Malara VP. Successful Retreatment of Lyme disease. Presented at Fifth International Conference on Lyme Borreliosis, May 30-June 2, 1992, Arlington, VA.
48. Cameron DJ. The nursing home as a teaching institution. N Y Med College Quarterly 1988;8;2-3.
49. Gambert SR, Crimmons D, Cameron DJ, et al. Geriatric assessment of the mentally retarded elderly. N Y Med College Quarterly 1988;8:2-3.
50. Cameron DJ, Gambert SR, et al. A specialized dementia unit: cost and benefit analysis. N Y Med College Quarterly 1987;7:103-107.
51. Benson D, Gambert SR, Cameron DJ. Cognitive Function. Manual of Medical Therapeutics. Plenum, 1986.
52. Cameron DJ, Gambert SR. Preventive Medicine. Manual of Medical Therapeutics. Plenum, 1986.
53. Gambert SR, Cameron DJ. Hypertension. Manual of Medical therapeutics. Plenum, 1986.
54. Cameron DJ, Mulvihill M, Bronheim H. Reliability and validity of the diagnosis of delirium using DSM III criteria. Research Thesis, School of Public Health, University of Minnesota, 1985.
55. Cameron D. Ageism. University of Minnesota Daily, 1980.
56. MacCoss M, Cameron DJ. Facile detritylation of nucleoside derivatives by using trifluoroactetic acid. Carbohydrate Res 1978;600:206-209.

Journal Publications

Journal Publications

1. Rhee H, Cameron DJ. Lyme "Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with Streptococcus infections (PANDAS): An Overview." International Journal of General Medicine, accepted for publication, 2011.
2. Cameron DJ. Proof that chronic Lyme disease exists. Interdiscip Perspect Infect Dis. 2010;2010:876450.
3. Cameron DJ. Obstacles to trials of chronic Lyme disease in actual practice. Minerva Med. 2009 Oct;100(5).
4. Cameron DJ. Insufficient evidence to deny antibiotic treatment to Lyme disease patients. Med Hypotheses. 2009 June; (72)6:688-91.
5. Cameron DJ. Clinical trials validate the severity of persistent Lyme disease symptoms. Med Hypotheses. 2009 Feb;72(2):153-6.
6. Cameron DJ. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med. 2008 Oct;99(5):489-96.
7. Cameron DJ. An appraisal of “chronic Lyme disease”. New England Journal of Medicine. 2008 Jan;24;358(4):429-30.
8. Cameron DJ. Lyme disease Clinical Trial – Consequences of Delayed Treatment, J Eval Clin Pract. 2007 Jun;13(3):470-2.
9. Cameron DJ. Lyme disease Clinical Trial – Generalizability in Two Clinical Trials of Lyme Disease, Epidemiol Perspect Innov. 2006 Oct 17;3:12.
10. Cameron DJ, Gaito A, Harris N. et al. The ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti-infect. Ther. 2(1), 2004.
11. Cameron DJ. Effectiveness of early Lyme disease treatment. Am J Med 1993;94:553 (letter).
12. Cameron DJ. Cognitive function in late Lyme borreliosis. Arch Neurol 1992;49:1011(letter).
13. Cameron DJ. Borrelia burgdorferi in the central nervous system. JAMA 1992;268:872(letter).
14. Thomas RI, Cameron DJ, Fahs MC. A prospective study of delirium and prolonged hospital stay. Arch Gen Psychiatry 1988;45:937-9400.
15. Cameron DJ, Mulvihill M, Bronheim H, Thomas R. Delirium: A test of the DSM III criteria on medical inpatients. J Am Geriatr Soc 1987;35:1007-1010.
16. Benson DM, Cameron DJ, Humbach E, Servino L, Gambert SR. Establishment and impact of a dementia unit within the nursing home. J Am Geriat Soc 1987;35:1007-1010.
17. Cameron DJ, Mernick M. Do-not-resuscitate status of delirious patients. JAMA 1986; Letter to the Editor.
18. Gambert SR, Cameron D, et al. Old age in the retarded. J Am Geriat Soc 1986;34:835. Letter to the Editor.
19. Zeveloff S, Cameron DJ, et al. Diffuse lymphadenopathy and anasarca in a 65-year-old woman. N Y state J Med 1984;85:306-311.
20. MacCoss M, Cameron DJ. Facile detritylation of nucleoside derivatives by using trifluoroactetic acid. Carbohydrate Res 1978;600:206-209.

Patient Care Approach

Dr. Daniel Cameron & Associates is dedicated to improving the lives and standard of care for patients suffering from Lyme disease and other tick-borne illnesses. Dr. Cameron, a board-certified internist and epidemiologist, has more than 25 years of experience diagnosing and treating Lyme disease in both adolescents and adults. learn more →

Patient Forms

As a first time patient we have made it easy for you by offering health related forms online. Your forms will be delivered directly to our office when you complete the forms. By using this service your personal health information is protected.  learn more →

Hours and Location

Dr. Cameron and Associates is 35 miles north of Manhattan in Westchester county, offering easy access from anywhere in the New York Metropolitan area by car or public transportation. The office is located at 657 East Main Street in Mt. Kisco, New York. learn more →